Journal article

New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers.

Kamil Wolyniec, Dennis A Carney, Sue Haupt, Ygal Haupt

Front Oncol | Published : 2013

Abstract

The tumor suppressor function of the promyelocytic leukemia (PML) protein was first identified as a result of its dysregulation in acute promyelocytic leukemia, however, its importance is now emerging far beyond hematological neoplasms, to an extensive range of malignancies, including solid tumors. In response to stress signals, PML coordinates the regulation of numerous proteins, which activate fundamental cellular processes that suppress tumorigenesis. Importantly, PML itself is the subject of specific post-translational modifications, including ubiquitination, phosphorylation, acetylation, and SUMOylation, which in turn control PML activity and stability and ultimately dictate cellular fa..

View full abstract